Filing Details
- Accession Number:
- 0001209191-20-055015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-16 12:21:06
- Reporting Period:
- 2020-10-14
- Accepted Time:
- 2020-10-16 12:21:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1683553 | Spruce Biosciences Inc. | SPRB | Pharmaceutical Preparations (2834) | 812154263 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1780235 | Niall O'donnell | C/O Rivervest Venture Funds 101 S. Hanley Rd., Ste. 1850 St. Louis MO 63105 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-10-14 | 445,905 | $0.00 | 445,905 | No | 4 | C | Indirect | By RiverVest Venture Fund IV, L.P. |
| Common Stock | Acquisiton | 2020-10-14 | 250,000 | $15.00 | 695,905 | No | 4 | P | Indirect | By RiverVest Venture Fund IV, L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | By RiverVest Venture Fund IV, L.P. |
| No | 4 | P | Indirect | By RiverVest Venture Fund IV, L.P. |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series B Preferred Stock | Disposition | 2020-10-14 | 2,916,664 | $0.00 | 445,905 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect |
Footnotes
- Each share of Series B Preferred Stock automatically converted into 0.152881822351322 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering on October 14, 2020 (on an adjusted basis, after giving effect to the 1-for-6.541 reverse stock split of the common stock effected by the Issuer on October 2, 2020). The shares have no expiration date.
- RiverVest Venture Partners IV, L.P. is the general partner of RiverVest Venture Fund IV, L.P. The Reporting Person is a manager of RiverVest Venture Partners IV, LLC, the sole general partner of RiverVest Venture Partners IV, L.P., and as a result may be deemed to share dispositive voting and investment power with respect to the shares held by RiverVest Venture Partners IV, L.P. The Reporting Person disclaims beneficial ownership of all shares held by RiverVest Venture Partners IV, L.P. except to the extent of his pecuniary interests therein.
- The shares were purchased in the Issuer's initial public offering.
Billionaire Hedge Funds
